FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

16206111000001105: MaxEPA 1g capsules (Lexon (UK) Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Dec 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
57141201000001110 MaxEPA 1g capsules (Lexon (UK) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
57141301000001118 MaxEPA 1g capsules (Lexon (UK) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
MaxEPA 1g capsules (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
MaxEPA 1g capsules (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
MaxEPA 1g capsules (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel Import - supplier (qualifier value) false Inferred relationship Existential restriction modifier
MaxEPA 1g capsules (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
MaxEPA 1g capsules (Lexon (UK) Ltd) Is a Product containing precisely fish derived omega 3 fatty acid 1 gram/1 each conventional release oral capsule true Inferred relationship Existential restriction modifier
MaxEPA 1g capsules (Lexon (UK) Ltd) Has active ingredient Fish derived omega 3 fatty acid false Inferred relationship Existential restriction modifier
MaxEPA 1g capsules (Lexon (UK) Ltd) Has manufactured dose form Conventional release oral capsule true Inferred relationship Existential restriction modifier
MaxEPA 1g capsules (Lexon (UK) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
MaxEPA 1g capsules (Lexon (UK) Ltd) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
MaxEPA 1g capsules (Lexon (UK) Ltd) Has specific active ingredient Eicosapentaenoic acid true Inferred relationship Existential restriction modifier
MaxEPA 1g capsules (Lexon (UK) Ltd) Has specific active ingredient Docosahexaenoic acid true Inferred relationship Existential restriction modifier
MaxEPA 1g capsules (Lexon (UK) Ltd) Has dispensed dose form Capsule true Inferred relationship Existential restriction modifier
MaxEPA 1g capsules (Lexon (UK) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
MaxEPA 1g capsules (Lexon (UK) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
MaxEPA 1g capsules (Lexon (UK) Ltd) Is a MaxEPA true Inferred relationship Existential restriction modifier
MaxEPA 1g capsules (Lexon (UK) Ltd) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
MaxEPA 1g capsules (Lexon (UK) Ltd) 200 capsule Has AMP True MaxEPA 1g capsules (Lexon (UK) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start